CRL insider plans Rule 144 stock sale

CRL reports a planned disposition of common stock under a Rule 144 notice.

Rhea-AI Filing Summary

CRL reports a planned disposition of common stock under a Rule 144 notice. The reporting shareholder, Shannon M. Parisotto, lists 3,714 shares of common stock to be sold for cash on 08/11/2026, with UBS Financial Services, Inc. as broker. The shares are to be issued through an exercise of stock options.

The filing also notes that during the past three months Parisotto sold 5,046 shares of common stock on 08/05/2026 for total proceeds of $1,327,098.00.

Key Figures

Shares to be sold: 3,714 shares Sale date: 08/11/2026 Prior shares sold: 5,046 shares +1 more

4 metrics

Shares to be sold 3,714 shares Planned cash sale of common stock on 08/11/2026

Sale date 08/11/2026 Proposed transaction date for the 3,714-share sale

Prior shares sold 5,046 shares Common stock sold during past three months on 08/05/2026

Prior sale proceeds $1,327,098.00 Total proceeds from 5,046-share sale on 08/05/2026

Key Terms

Form 144, exercise of stock options, Securities To Be Sold

3 terms

Form 144 regulatory

"CRL reports a planned disposition of common stock under a Rule 144 notice."

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

exercise of stock options financial

"The shares are to be issued through an exercise of stock options."

Securities To Be Sold regulatory

"144: Securities To Be Sold Common | 08/11/2026 | Exercise of Stock Options"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock sale is disclosed for CRL in this Form 144 filing?

The filing discloses a planned sale of 3,714 shares of CRL common stock for cash, with a proposed transaction date of 08/11/2026, following an exercise of stock options.

Who is the shareholder filing the Form 144 for CRL and what are they selling?

The shareholder is Shannon M. Parisotto, who plans to sell 3,714 shares of CRL common stock obtained through the exercise of stock options, with UBS Financial Services, Inc. handling the transaction.

Which broker is handling the planned CRL stock sale in this Form 144?

The planned CRL stock sale is listed with UBS Financial Services, Inc., located at 11 Madison Ave, 4th Floor, New York, NY 10010, as the broker for the 3,714-share common stock transaction.

What prior CRL stock sales by the filer are reported in the last three months?

The filer reports a prior sale of 5,046 shares of CRL common stock on 08/05/2026, with total proceeds of $1,327,098.00 during the past three months.

What is the relationship between the CRL Form 144 sale and stock options?

The 3,714 shares of CRL common stock covered by the Form 144 are designated as arising from an exercise of stock options by the issuer, with the sale for cash planned for 08/11/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/11/2026 - 04:07 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001952784
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
SEC File Number	001-15943
Address of Issuer	251 BALLARDVALE ST WILMINGTON MASSACHUSETTS 01887
Phone	781-222-6000
Name of Person for Whose Account the Securities are To Be Sold	Parisotto Shannon M
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc 11 Madison Ave 4th Floor New York NY 10010	3714	1038657.24	47738872	08/11/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/11/2026	Exercise of Stock Options	Issuer			3714	08/11/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Shannon M. Parisotto 251 BALLARDVALE ST WILMINGTON MA 01887	Common	08/05/2026	5046	1327098.00

144: Remarks and Signature

Remarks
Date of Notice	08/11/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/04/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for Shannon Parisotto
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)